1. Home
  2. CTKB

as 12-20-2024 3:34pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Nasdaq

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Founded: 1990 Country:
United States
United States
Employees: N/A City: FREMONT
Market Cap: 708.8M IPO Year: 2021
Target Price: $9.17 AVG Volume (30 days): 646.8K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.08 EPS Growth: N/A
52 Week Low/High: $4.66 - $9.87 Next Earning Date: 11-05-2024
Revenue: $201,210,000 Revenue Growth: 9.88%
Revenue Growth (this year): 8.18% Revenue Growth (next year): 13.21%

CTKB Daily Stock ML Predictions

Share on Social Networks: